Royalty Pharma PLC
RPRX37.560USD
+0.450+1.21%
交易中 （美东）报价延迟15分钟
15.99B总市值
14.63市盈率 TTM
关于 Royalty Pharma PLC 公司
Royalty Pharma plc 是生物制药专利使用费的买家，也是整个生物制药行业创新的资助者。该公司与来自学术机构、研究医院和非营利组织的创新者合作，合作对象包括中小型生物技术公司和全球制药公司。该公司以直接和间接的方式资助生物制药行业的创新。直接资助是指它与公司合作，共同资助后期临床试验和新产品发布，以换取未来的专利使用费。间接资助是指它从原始创新者那里获得现有的专利使用费。其投资组合包括 35 多种商业产品的特许权使用费，其中包括 Vertex 的 Trikafta、GSK 的 Trelegy、罗氏的 Evrysdi、强生的 Tremfya、Biogen 的 Tysabri 和 Spinraza、艾伯维和强生的 Imbruvica、安斯泰来和辉瑞的 Xtandi、诺华的 Promacta、辉瑞的 Nurtec ODT 和吉利德的 Trodelvy，以及 14 种处于开发阶段的候选产品。
公司简介
公司代码RPRX
公司名称Royalty Pharma PLC
上市日期Jun 16, 2020
CEOMr. Pablo Legorreta
员工数量99
证券类型Ordinary Share
年结日Jun 16
公司地址110 East 59th Street
城市NEW YORK
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编10022
电话12128830200
网址https://www.royaltypharma.com/
公司代码RPRX
上市日期Jun 16, 2020
CEOMr. Pablo Legorreta
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Henry A. Fernandez
Mr. Henry A. Fernandez
Lead Independent Director
Lead Independent Director
114.23K
+0.94%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
74.39K
+11.40%
Dr. Bonnie L. Bassler, Ph.D.
Dr. Bonnie L. Bassler, Ph.D.
Independent Director
Independent Director
61.83K
+1.75%
Dr. Ted Wendell Love, M.D.
Dr. Ted Wendell Love, M.D.
Independent Director
Independent Director
44.55K
+20.61%
Dr. Carole Ho, M.D.
Dr. Carole Ho, M.D.
Independent Director
Independent Director
8.56K
--
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
8.56K
--
Dr. Vlad Coric, M.D.
Dr. Vlad Coric, M.D.
Independent Director
Independent Director
--
--
Ms. Catherine (Cathy) Engelbert
Ms. Catherine (Cathy) Engelbert
Independent Director
Independent Director
--
--
Mr. Pablo Legorreta
Mr. Pablo Legorreta
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. David Charles Hodgson
Mr. David Charles Hodgson
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Henry A. Fernandez
Mr. Henry A. Fernandez
Lead Independent Director
Lead Independent Director
114.23K
+0.94%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
74.39K
+11.40%
Dr. Bonnie L. Bassler, Ph.D.
Dr. Bonnie L. Bassler, Ph.D.
Independent Director
Independent Director
61.83K
+1.75%
Dr. Ted Wendell Love, M.D.
Dr. Ted Wendell Love, M.D.
Independent Director
Independent Director
44.55K
+20.61%
Dr. Carole Ho, M.D.
Dr. Carole Ho, M.D.
Independent Director
Independent Director
8.56K
--
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
8.56K
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月3日 周日
更新时间: 8月3日 周日
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
8.66%
Fidelity Management & Research Company LLC
8.17%
Morgan Stanley Investment Management Inc. (US)
7.86%
Nogra Group Sicaf SIF S.A.
7.10%
BlackRock Institutional Trust Company, N.A.
3.85%
Other
64.36%
持股股东
持股股东
占比
The Vanguard Group, Inc.
8.66%
Fidelity Management & Research Company LLC
8.17%
Morgan Stanley Investment Management Inc. (US)
7.86%
Nogra Group Sicaf SIF S.A.
7.10%
BlackRock Institutional Trust Company, N.A.
3.85%
Other
64.36%
股东类型
持股股东
占比
Investment Advisor
44.58%
Investment Advisor/Hedge Fund
25.84%
Corporation
7.10%
Hedge Fund
4.77%
Research Firm
2.69%
Individual Investor
1.82%
Pension Fund
1.81%
Sovereign Wealth Fund
1.25%
Bank and Trust
1.10%
Other
9.04%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
1042
394.62M
93.65%
-818.89K
2025Q1
1055
377.46M
89.18%
-34.89M
2024Q4
994
390.78M
89.67%
-2.48M
2024Q3
951
382.53M
85.35%
-9.94M
2024Q2
919
378.24M
83.94%
-8.34M
2024Q1
889
372.56M
83.37%
-16.43M
2023Q4
859
370.68M
82.95%
-12.48M
2023Q3
813
362.54M
80.78%
-38.03M
2023Q2
800
380.55M
84.91%
+5.32M
2023Q1
793
365.16M
82.61%
-4.13M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
36.48M
8.66%
-674.20K
-1.81%
Mar 31, 2025
Fidelity Management & Research Company LLC
34.42M
8.17%
+9.76M
+39.57%
Mar 31, 2025
Morgan Stanley Investment Management Inc. (US)
33.11M
7.86%
+895.26K
+2.78%
Mar 31, 2025
Nogra Group Sicaf SIF S.A.
29.93M
7.1%
-6.08M
-16.88%
May 02, 2025
BlackRock Institutional Trust Company, N.A.
16.23M
3.85%
-1.12M
-6.47%
Mar 31, 2025
Baillie Gifford & Co.
13.40M
3.18%
-732.23K
-5.18%
Mar 31, 2025
Swedbank Robur Fonder AB
12.16M
2.89%
-6.70K
-0.06%
Mar 31, 2025
Viking Global Investors LP
10.56M
2.51%
-1.64M
-13.47%
Mar 31, 2025
State Street Global Advisors (US)
9.52M
2.26%
-244.03K
-2.50%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
Formidable ETF
5.13%
iShares U.S. Pharmaceuticals ETF
4.84%
SPDR S&P Pharmaceuticals ETF
3.79%
iShares Focused Value Factor ETF
2.96%
Invesco Biotechnology & Genome ETF
2.83%
VictoryShares Free Cash Flow ETF
2.78%
Bushido Capital US Equity ETF
2.05%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.76%
ProShares Ultra Nasdaq Biotechnology
1.73%
Fidelity Stocks for Inflation ETF
1.66%
查看更多
Formidable ETF
占比5.13%
iShares U.S. Pharmaceuticals ETF
占比4.84%
SPDR S&P Pharmaceuticals ETF
占比3.79%
iShares Focused Value Factor ETF
占比2.96%
Invesco Biotechnology & Genome ETF
占比2.83%
VictoryShares Free Cash Flow ETF
占比2.78%
Bushido Capital US Equity ETF
占比2.05%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比1.76%
ProShares Ultra Nasdaq Biotechnology
占比1.73%
Fidelity Stocks for Inflation ETF
占比1.66%
分红派息
近5年累计派现
1.47B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Jan 09, 2025
RPRX.NB Interim Cash Dividend of gross USD 0.22 paid on Mar 10, 2025 going ex on Feb 21, 2025
Feb 21, 2025
Mar 10, 2025
Feb 21, 2025
Oct 11, 2024
RPRX.NB Final Cash Dividend of gross USD 0.21 paid on Dec 10, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 10, 2024
Nov 15, 2024
Jul 17, 2024
RPRX.NB Interim Cash Dividend of gross USD 0.21 paid on Sep 13, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 13, 2024
Aug 16, 2024
Apr 17, 2024
RPRX.NB Interim Cash Dividend of gross USD 0.21 paid on Jun 14, 2024 going ex on May 16, 2024
May 17, 2024
Jun 14, 2024
May 16, 2024
Jan 19, 2024
RPRX.NB Interim Cash Dividend of gross USD 0.21 paid on Mar 15, 2024 going ex on Feb 15, 2024
Feb 16, 2024
Mar 15, 2024
Feb 15, 2024
Oct 16, 2023
RPRX.NB Final Cash Dividend of gross USD 0.2 paid on Dec 15, 2023 going ex on Nov 16, 2023
Nov 17, 2023
Dec 15, 2023
Nov 16, 2023
Jul 17, 2023
RPRX.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 15, 2023 going ex on Aug 17, 2023
Aug 18, 2023
Sep 15, 2023
Aug 17, 2023
Apr 17, 2023
RPRX.NB Interim Cash Dividend of gross USD 0.2 paid on Jun 15, 2023 going ex on May 18, 2023
May 19, 2023
Jun 15, 2023
May 18, 2023
Jan 09, 2023
RPRX.NB Interim Cash Dividend of gross USD 0.2 paid on Mar 15, 2023 going ex on Feb 15, 2023
Feb 16, 2023
Mar 15, 2023
Feb 15, 2023
Oct 17, 2022
RPRX.NB Final Cash Dividend of gross USD 0.19 paid on Dec 15, 2022 going ex on Nov 17, 2022
Nov 18, 2022
Dec 15, 2022
Nov 17, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
